TAF9P3

Across TCGA pan-cancer cohorts, TAF9P3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated TAF9P3 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TAF9P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated TAF9P3 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

HNSC, UCS, and LAML are the cancer types where TAF9P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.723	0.549	<.001	100	view →
UCS	DFS	Tertile	II,III,IV	0.529	0.116	.001	60	view →
LAML	DFS	Median	All	0.542	0.246	.003	22	view →
ESCA	OS	Median	IV	0.222	0.698	.006	18	view →
CHOL	OS	Median	All	0.779	0.372	.001	12	view →
COAD	OS	Median	All	0.926	0.809	.002	12	view →
ACC	DFS	Median	III,IV	0.226	0.626	.001	12	view →
SKCM	OS	Tertile	IV	0.730	0.238	.007	10	view →
BLCA	OS	Median	II,III,IV	0.775	0.655	.006	9	view →
THYM	DFS	Median	All	0.938	0.791	.004	8	view →
LUSC	OS	Median	All	0.810	0.739	.007	8	view →
CESC	DFS	Tertile	All	0.768	0.859	.024	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

TAF9P3–HNSC (OS)

Open the HNSC breakdown →